Active investment

Leading data-driven global platform for rare disease diagnosis

About Centogene

Founded in 2006, Centogene is the world’s leading rare disease diagnostic platform.

The company has the most comprehensive curated database of genotype-phenotype correlations and clinical data on rare inherited diseases, collected from physicians and clinics in over 110 countries.

Based on its in-depth disease knowledge and diagnostic testing activities, Centogene offers pharmaceutical companies high-quality patient identification/monitoring and biomarker development services.

Key figures

Fund DPE Fund II
Sector Healthcare
Location Germany
Investment in the year 2017
Turnover 2022 € 47.5 million
Number of employees N/A